1-(2,5-dimethoxyphenyl)-4,4,4-trifluorobutane-1,3-dione, 25g

1-(2,3-Dihydro-benzo[1,4]dioxin-6-yl)-5-oxo-pyrrolidine-3-carboxylic acid, 95.0%, 1g

2,2,4,4-Tetramethylcyclobutane-1,3-diol, 95.0%, 1g

trans,trans-4'-Ethylbicyclohexyl-4-carboxylic Acid>98.0%(GC)(T)5g

Ocular WF 15x/16 mm, tubo de Ø 23,2 mm

1-azido-2-(methylsulfonyl)ethane, 95.0%, 250mg

3-Methyl-1,2-butadiene>97.0%(GC)1mL

(R)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(3-nitrophenyl)propanoic acid, 98%, 1g

3-(1-Methyl-1H-1,2,4-triazol-3-yl)aniline, 97%, 100mg

2-(4-Fluorophenyl)cyclopropanecarboxylic acid, 95.0%, 100mg

2-Chloro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile, 98%, 5g

(R)-1-(benzyloxycarbonyl)-2-methylpyrrolidine-2-carboxylic acid, 98%, 500mg

4-Nitro-3-picoline-n-oxide, 98.0%, 1g